APA (7th ed.) Citation

KA, M., MA, N., X, Z., PR, L., S, S., SM, L., . . . DL, M. (2019). The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Nature communications, 10(1), 4682. https://doi.org/10.1038/s41467-019-12657-w

Chicago Style (17th ed.) Citation

KA, Michaelis, et al. "The TLR7/8 Agonist R848 Remodels Tumor and Host Responses to Promote Survival in Pancreatic Cancer." Nature Communications 10, no. 1 (2019): 4682. https://doi.org/10.1038/s41467-019-12657-w.

MLA (9th ed.) Citation

KA, Michaelis, et al. "The TLR7/8 Agonist R848 Remodels Tumor and Host Responses to Promote Survival in Pancreatic Cancer." Nature Communications, vol. 10, no. 1, 2019, p. 4682, https://doi.org/10.1038/s41467-019-12657-w.